The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients: A retrospective observational cohort study from recent regional outbreaks in China
Open Access
- 7 November 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 988694
Abstract
Object: This study attempted to explore the effects of vaccination on disease severity and the factors for viral clearance and hospitalization in omicron-infected patients.Methods: The clinical manifestations of 3,265 Omicron-infected patients (BA.2 lineage variant; the Omicron group) were compared with those of 226 Delta-infected patients (the Delta group). A Multi-class logistic regression model was employed to analyze the impacts of vaccination doses and intervals on disease severity; a logistic regression model to evaluate the risk factors for hospitalization; R 4.1.2 data analysis to investigate the factors for time for nucleic acid negativization (NAN).Results: Compared with the Delta group, the Omicron group reported a fast transmission, mild symptoms, and lower severity incidence, and a significant inverse correlation of vaccination dose with clinical severity (OR: 0.803, 95%CI: 0.742-0.868, p<0.001). Of the 7 or 5 categories of vaccination status, the risk of severity significantly decreased only at ≥21 days after three doses (OR: 0.618, 95% CI: 0.475-0.803, p<0.001; OR: 0.627, 95% CI: 0.482-0.815, p<0.001, respectively). The Omicron group also reported underlying illness as an independent factor for hospitalization, sore throat as a protective factor, and much shorter time for NAN [15 (12,19) vs. 16 (12,22), p<0.05]. NAN was associated positively with age, female gender, fever, cough, and disease severity, but negatively with vaccination doses.Conclusion: Booster vaccination should be advocated for COVID-19 pandemic-related control and prevention policies and adequate precautions should be taken for patients with underlying conditions.Keywords
All Related Versions
Funding Information
- Natural Science Foundation of Fujian Province
- Natural Science Foundation of Fujian Province
This publication has 32 references indexed in Scilit:
- SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccineScience Immunology, 2022
- SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivoNature, 2022
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature, 2022
- Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concernBMJ, 2021
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralizationNature, 2021
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralizationNature, 2021
- A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernmedRxiv, 2021
- Description and analysis of representative COVID-19 cases–A retrospective cohort studyPLOS ONE, 2021
- Aging in COVID-19: Vulnerability, immunity and interventionAgeing Research Reviews, 2021
- Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wardsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020